Facebook
Twitter
Telegram
Report an ErrorOncoSec Medical Incorporated Financial Ratios 2011-2024 | ONCS
Annual Financial Ratios OncoSec Medical Incorporated
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | -1.3 | -0.5 | -1.5 | -0.9 | -1.1 | -3.1 | -7.3 | -4.3 | -6.0 | -12.6 |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.9 | -1.4 | -2.6 | -4.3 | -9.8 | -1.1 | -1.6 | -1.7 | -1.3 | -1.3 | -0.0 | -0.1 |
EV (Enterprise Value) |
9.06 M | -27.8 M | 51.6 M | -5.15 M | 63.7 M | 12.1 M | 4.01 M | 36.9 M | 51.1 M | 27.7 M | 12 M | 53.1 M |
EBITDA per Share |
-0.94 | -1.46 | -2.57 | -4.28 | -8.92 | -10.4 | -16.1 | -16.2 | -11.7 | -11.9 | -14.3 | -4.56 |
EV/EBITDA |
0.6 | -0.9 | 0.4 | -1.6 | -0.4 | 0.0 | -1.7 | -4.5 | -4.1 | -1.9 | -31.2 | |
PEG |
- | - | 0.03 | 0.01 | 0.2 | 0.03 | 0.44 | -0.08 | 0.51 | -0.06 | 0.18 | -0.0 |
P/B |
- | - | 4.0 | 0.6 | 2.6 | 1.8 | 1.0 | 2.0 | 2.3 | 6.5 | 3.2 | -20.1 |
P/CF |
- | - | -1.7 | -0.5 | -2.6 | -1.1 | -1.5 | -3.5 | -9.2 | -5.5 | -3.3 | -29.3 |
ROE % |
-558.64 | -118.63 | -304.63 | -124.70 | -170.72 | -200.54 | -95.85 | -64.97 | -31.55 | -150.88 | -53.43 | 158.94 |
ROA % |
-156.23 | -80.26 | -141.30 | -101.28 | -129.39 | -140.81 | -82.97 | -59.69 | -30.49 | -109.84 | -31.83 | -66.25 |
ROCE % |
-604.93 | -127.06 | -214.63 | -122.08 | -147.99 | -181.20 | -92.90 | -64.97 | -31.39 | -149.08 | -102.25 | 196.04 |
Current Ratio |
1.4 | 3.1 | 2.4 | 5.7 | 4.9 | 3.7 | 8.5 | 11.6 | 29.0 | 2.9 | 2.7 | 0.4 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios OncoSec Medical Incorporated
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.25 | -4.5 | - | -0.16 | -0.37 | -5.51 | -0.86 | -0.25 | -1.27 | -0.49 | -2.19 | -0.49 | -1.33 | -0.92 | -2.7 | -0.92 | -0.31 | -1.37 | -0.58 | -0.14 | -0.27 | -0.26 | -0.28 | -0.26 | -0.42 | -0.29 | -0.39 | -0.37 | -0.38 | -1.19 | -0.71 | -0.48 | -0.01 | -0.96 | -0.03 | -0.37 | -0.02 | -0.05 | -0.04 | -0.01 | -0.05 | -0.02 | - | -0.01 | - | 0.05 | - | 0.05 |
EBITDA per Share |
-0.24 | -4.05 | - | -0.24 | -0.38 | -5.53 | -0.86 | -0.28 | -1.26 | -0.49 | -2.18 | -0.49 | -1.34 | -0.92 | -2.69 | -0.92 | -0.24 | -1.35 | -0.49 | -0.13 | -0.27 | -0.26 | -0.29 | -0.26 | -0.41 | -0.29 | -0.41 | -0.36 | -0.37 | -0.56 | -0.5 | -0.48 | -0.01 | -0.44 | -0.02 | -0.37 | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 | -0.02 | -0.04 | -0.03 | - | -0.02 | - | -0.02 |
ROE % |
678.91 | 706.68 | -101.30 | -164.15 | -151.97 | -559.17 | -606.57 | -687.86 | -736.53 | -340.81 | -323.14 | -282.90 | -265.23 | -291.06 | -257.31 | -225.99 | -192.24 | -160.05 | -173.56 | -156.13 | -181.23 | -178.50 | -158.63 | -126.88 | -91.69 | -81.87 | -84.02 | -80.74 | -79.08 | -78.04 | -63.92 | -53.11 | -45.83 | -52.30 | -54.07 | -82.16 | -82.51 | 68.73 | 6.74 | -9.29 | -43.70 | 292.22 | 834.65 | 1047.02 | 511.20 | 466.94 | 158.94 | -114.68 |
ROA % |
-128.70 | -115.75 | -59.10 | -101.63 | -96.09 | -149.69 | -167.18 | -202.89 | -230.34 | -187.25 | -190.25 | -165.17 | -153.60 | -176.33 | -157.89 | -159.73 | -152.12 | -125.76 | -133.77 | -117.49 | -131.18 | -130.39 | -118.78 | -100.31 | -78.86 | -71.60 | -74.81 | -73.04 | -72.57 | -71.59 | -59.81 | -50.33 | -43.19 | -45.21 | -45.87 | -64.10 | -80.97 | -155.33 | -180.04 | -184.65 | -185.38 | -30.41 | 71.80 | 37.38 | 47.01 | 65.46 | -66.25 | 47.80 |
ROCE % |
557.22 | 581.84 | -126.10 | -189.31 | -156.83 | -559.88 | -605.76 | -686.55 | -730.63 | -339.06 | -323.04 | -283.54 | -267.52 | -279.10 | -244.55 | -202.05 | -167.50 | -149.12 | -163.12 | -156.26 | -181.90 | -178.95 | -159.07 | -127.31 | -94.18 | -84.37 | -86.32 | -83.04 | -79.06 | -78.04 | -63.92 | -53.12 | -46.53 | -52.70 | -54.05 | -81.89 | -83.25 | -5.44 | -66.75 | -83.25 | -115.29 | -378.78 | -510.00 | -456.07 | -154.83 | -205.61 | 0.29 | 50.50 |
Current Ratio |
2.3 | 0.9 | 1.4 | 2.0 | 3.2 | 2.7 | 3.1 | 3.1 | 1.2 | 1.9 | 1.9 | 1.9 | 4.3 | 2.9 | 5.3 | 5.3 | 5.4 | 4.6 | 4.1 | 4.1 | 5.3 | 3.6 | 3.4 | 3.4 | 7.6 | 6.3 | 7.4 | 7.4 | 21.7 | 9.6 | 12.3 | 12.3 | 22.1 | 27.0 | 29.8 | 33.5 | 4.0 | 9.2 | 3.7 | 3.7 | 0.6 | 1.9 | 2.5 | 2.5 | - | 1.2 | 0.7 | 0.7 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency